Endocrine Metabolic & Immune Disorders-Drug Targets

metrics 2024

Fostering Insights for Future Therapeutics

Introduction

Endocrine Metabolic & Immune Disorders-Drug Targets, published by Bentham Science Publishers, is a premier journal focused on the intricate interplay between endocrinology, metabolism, and immune response, with a particular emphasis on drug targets. Established in 2006 and set to continue its influence until 2024, this journal serves as a crucial platform for researchers and professionals to communicate significant advances in understanding metabolic and immune disorders, making it an invaluable resource in the realms of Endocrinology and Immunology. With an impact factor positioned within the Q3 category for both Endocrinology, Diabetes and Metabolism, and Immunology and Allergy as of 2023, the journal stands at the crossroads of critical research and clinical application, facilitating ongoing dialogue among the scientific community. Although currently not open access, its dedication to high-quality peer-reviewed articles ensures that cutting-edge research remains accessible to those invested in enhancing therapeutic strategies. For researchers and practitioners alike, Endocrine Metabolic & Immune Disorders-Drug Targets is an essential conduit for the latest findings that can influence treatment paradigms and bolster the understanding of complex biological systems.

Metrics 2024

SCIMAGO Journal Rank0.49
Journal Impact Factor2.00
Journal Impact Factor (5 years)2.20
H-Index63
Journal IF Without Self2.00
Eigen Factor0.00
Normal Eigen Factor0.50
Influence0.37
Immediacy Index0.90
Cited Half Life3.80
Citing Half Life7.60
JCI0.42
Total Documents1569
WOS Total Citations2408
SCIMAGO Total Citations8512
SCIMAGO SELF Citations454
Scopus Journal Rank0.49
Cites / Document (2 Years)2.06
Cites / Document (3 Years)2.20
Cites / Document (4 Years)2.24

Metrics History

Rank 2024

Scopus

Endocrinology, Diabetes and Metabolism in Medicine
Rank #119/244
Percentile 51.23
Quartile Q2
Immunology and Allergy in Medicine
Rank #131/233
Percentile 43.78
Quartile Q3

IF (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 134/186
Percentile 28.20
Quartile Q3
IMMUNOLOGY
Rank 144/181
Percentile 20.70
Quartile Q4
PHARMACOLOGY & PHARMACY
Rank 222/354
Percentile 37.40
Quartile Q3

JCI (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 149/186
Percentile 19.89
Quartile Q4
IMMUNOLOGY
Rank 139/181
Percentile 23.20
Quartile Q4
PHARMACOLOGY & PHARMACY
Rank 265/354
Percentile 25.14
Quartile Q3

Quartile History

Similar Journals

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Empowering Knowledge for Young Lives
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

CYTOKINE

Elevating the discourse in cytokine research and application.
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1043-4666Frequency: 12 issues/year

CYTOKINE is a prestigious peer-reviewed journal published by Academic Press Ltd - Elsevier Science Ltd, dedicated to advancing the field of immunology, biochemistry, and related biomedical sciences since its inception in 1989. With an ISSN of 1043-4666 and an E-ISSN of 1096-0023, this journal serves as a vital resource for researchers and professionals alike, offering cutting-edge research findings that delve into the roles and mechanisms of cytokines in health and disease. Recognized for its impactful contributions, CYTOKINE currently ranks in the Q2 quartile across several categories, including Biochemistry, Hematology, and Immunology, indicating its significant influence in these fields. Despite not offering open access, the journal maintains a high-quality standard, as evidenced by its robust Scopus rankings, including a notable 80th percentile in Medicine and Hematology. Researchers and students are encouraged to explore the latest findings and methodologies via CYTOKINE, as it continues to shape the future landscape of cytokine research and application.

Acta Endocrinologica-Bucharest

Bridging gaps in endocrine knowledge and practice.
Publisher: EDITURA ACAD ROMANEISSN: 1841-0987Frequency: 4 issues/year

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

EXPERIMENTAL AND MOLECULAR MEDICINE

Transforming insights into breakthroughs in clinical biochemistry.
Publisher: SPRINGERNATUREISSN: 1226-3613Frequency: 12 issues/year

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

CELL BIOCHEMISTRY AND FUNCTION

Fostering Collaboration in Biochemistry and Cell Biology
Publisher: WILEYISSN: 0263-6484Frequency: 8 issues/year

CELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Exploring Innovations in Endocrine Science
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Journal of Endocrinology and Metabolism

Pioneering research for a healthier future in metabolism and endocrinology.
Publisher: ELMER PRESS INCISSN: 1923-2861Frequency: 4 issues/year

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Navigating the complexities of endocrine and metabolic health.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Case Reports in Endocrinology

Connecting research and practice in endocrinology.
Publisher: HINDAWI LTDISSN: 2090-6501Frequency:

Case Reports in Endocrinology is a pioneering open access journal published by HINDAWI LTD, dedicated to advancing the field of endocrinology through the publication of case reports that illuminate the complexities of hormone-related disorders and metabolic issues. With its ISSN 2090-6501 and E-ISSN 2090-651X, the journal has been accessible since 2011, inviting contributions from researchers, clinicians, and students worldwide. Based in the United States, Case Reports in Endocrinology aims to disseminate critical insights and unique case analyses that contribute to the broader understanding of endocrinological conditions. While currently ranked Q4 in Endocrinology, Diabetes, and Metabolism, with Scopus placing it in the 29th percentile, the journal strives to enhance its impact and visibility. By fostering an environment for knowledge sharing and collaboration in a rapidly evolving field, this journal serves as an essential resource for those looking to deepen their understanding of endocrinological complexities and improve clinical practices.

Minerva Endocrinology

Championing Rigorous Science in Hormonal Disorders
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-6507Frequency: 4 issues/year

Minerva Endocrinology, published by EDIZIONI MINERVA MEDICA in Italy, serves as a pivotal platform for advancing knowledge in the field of endocrinology, diabetes, and metabolism. With its ISSN 2724-6507 and E-ISSN 2724-6116, the journal has rapidly established a reputable position in academia, achieving impressive rankings such as Q3 in both Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. This enables Minerva Endocrinology to attract a diverse readership, including researchers, healthcare professionals, and students committed to understanding the complexities of endocrine disorders. With annual publications covering breakthroughs and innovative research covering converged years from 2021 to 2024, the journal is devoted to facilitating the dissemination of high-quality studies that advance clinical and laboratory practices. Despite its >Open Access< status, the journal encourages submissions that reflect rigorous scientific inquiry and uphold the highest standards of scholarship, thereby enhancing its role as a significant contributor to the field of internal medicine and endocrinology.